BioCardia (BCDA) EBIT Margin Growth (5y) (2016 - 2024)
Powered by 
Analysis
BioCardia (BCDA) EBIT Margin Growth (5y) (2016 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.56 Bn | 2.60 Bn | 251.50 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.19 Bn | 1.40 Bn | 251.87 Mn |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn |
| 10 | BioCardia | 13.18 Mn | 9.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -5.06 Mn |
| Mar 31, 2024 | -242,942.00 |
| Dec 31, 2023 | -1.25 Mn |
| Sep 30, 2023 | 352,227.00 |
| Jun 30, 2023 | -666,724.00 |
| Mar 31, 2023 | -366,528.00 |
| Dec 31, 2022 | 67,583.00 |
| Sep 30, 2022 | 89,430.00 |
| Jun 30, 2022 | 239,374.00 |
| Mar 31, 2022 | -344,646.00 |
| Dec 31, 2021 | -184,671.00 |
| Sep 30, 2021 | 110,777.00 |
| Jun 30, 2021 | -409,958.00 |
| Mar 31, 2021 | -585,638.00 |
| Jun 30, 2018 | -136,937.00 |
| Mar 31, 2018 | -175,067.00 |
| Dec 31, 2017 | -308,300.00 |
| Sep 30, 2017 | -190,085.00 |
| Jun 30, 2017 | -187,353.00 |
| Mar 31, 2017 | -157,127.00 |